Despite the recent implementation of immunotherapy as a single treatment or in combination
with chemotherapy for first-line treatment of advanced non-small cell lung cancer (NSCLC) …

The list of theranostic biomarkers for the care of patients with advanced stage or metastatic
non-small cell lung cancer has lengthened considerably these last few years. Moreover, the …

Simple Summary Due to the increase of molecular biomarkers to be characterized to tailor
therapeutic strategies for non-squamous non-small cell lung carcinoma (NS-NSCLC), it is …

The conventional method used to obtain a tumor biopsy for hepatocellular carcinoma (HCC)
is invasive and does not evaluate dynamic cancer progression or assess tumor …

The developmental potential of early embryos is mainly dictated by the quality of the oocyte.
Here, we explore the utility of the maternal spindle transfer (MST) technique as a …

The introduction of next-generation sequencing (NGS) in the molecular diagnostic
armamentarium is deeply changing pathology practice and laboratory frameworks. NGS …

Opinion Statement The quest for immunotherapy (IT) biomarkers is an element of highest
clinical interest in both solid and hematologic tumors. In non-small-cell lung cancer (NSCLC) …

Background: Assessment of actionable EGFR mutations is mandatory for treatment-naïve
advanced or metastatic non-squamous lung carcinoma (NSLC), but the results need to be …

Background NGS from plasma samples in non-squamous cell lung carcinoma (NSCC) can
aid in the detection of actionable genomic alterations. However, the absolute clinical value …

Up to the present time, tissue samples are mostly stored fixed in formalin and embedded in
paraffin or as frozen samples. However, the direct extraction and storage of DNA is also …